Treatment of amyloidosis associated with Alzheimer disease
US5242932A · kind A · utility
83Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1991 |
| Grant date | Sep 7, 1993 |
| Priority date | — |
| Expiry date | Dec 17, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Agents which modulate or affect the intracellular trafficking and processing of proteins in the mammalian cell can be utilized to affect the trafficking and processing of APP, thereby inhibiting production of Alzheimer type amyloidosis. Particularly useful agents are chloroquine and its related derivatives such as primaquine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.